verapamil has been researched along with amrubicin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kasai, D; Maeno, K; Miyazaki, M; Oguri, T; Ozasa, H; Sato, S; Takakuwa, O; Uemura, T | 1 |
Aukerman, SL; Chello, M; Covino, E; Menna, P; Minotti, G; Salvatorelli, E; Sung, V; Surapaneni, S | 1 |
2 other study(ies) available for verapamil and amrubicin
Article | Year |
---|---|
Over-expression of MDR1 in amrubicinol-resistant lung cancer cells.
Topics: Animals; Anthracyclines; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Drug Resistance, Neoplasm; LLC-PK1 Cells; Lung Neoplasms; Polymorphism, Single Nucleotide; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Neoplasm; RNA, Small Interfering; Swine; Verapamil | 2011 |
Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. I. Amrubicin accumulates to a lower level than doxorubicin or epirubicin.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Epirubicin; Female; Humans; In Vitro Techniques; Male; Middle Aged; Myocardium; Verapamil | 2012 |